Literature DB >> 12438447

Rescue of CD8 T cell-mediated antimicrobial immunity with a nonspecific inflammatory stimulus.

Roman A Tuma1, Rielle Giannino, Patrick Guirnalda, Ingrid Leiner, Eric G Pamer.   

Abstract

Reconstitution of protective immunity by adoptive transfer of pathogen-specific T cells has been successful in patients with compromised cellular immunity. The in vivo effectiveness of in vitro-expanded CD8 CTLs is variable, however. For example, adoptively transferred Listeria monocytogenes-specific CD8 CTLs only confer protective immunity if challenge infection occurs within 48 hours of T cell infusion. Herein we show that transferred CTLs persist in lymphoid compartments for many weeks, but that their response to bacterial challenge decreases during the first week following transfer. While T cells transferred less than 48 hours before infection proliferate, those transferred 7 days before infection die. Remarkably, treatment of mice with anti-CD40 at the time of T cell infusion reprograms transferred T cells, allowing them to proliferate and confer protective immunity upon bacterial challenge 7 days later. Our study demonstrates, for the first time to our knowledge that CD40-mediated stimuli can influence CD8 T cell activation independent of concurrent antigen exposure. The ability to modulate long-term responsiveness of CD8 T cells with a transient, nonspecific inflammatory stimulus has importation implications for adoptive immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438447      PMCID: PMC151819          DOI: 10.1172/JCI16356

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death.

Authors:  S J Brodie; B K Patterson; D A Lewinsohn; K Diem; D Spach; P D Greenberg; S R Riddell; L Corey
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

2.  Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells.

Authors:  L Lefrançois; J D Altman; K Williams; S Olson
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

Review 3.  Costimulation in antiviral immunity: differential requirements for CD4(+) and CD8(+) T cell responses.

Authors:  J K Whitmire; R Ahmed
Journal:  Curr Opin Immunol       Date:  2000-08       Impact factor: 7.486

Review 4.  CD40 and CD154 in cell-mediated immunity.

Authors:  I S Grewal; R A Flavell
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

Review 5.  T-cell therapy of cytomegalovirus and human immunodeficiency virus infection.

Authors:  S R Riddell; P D Greenberg
Journal:  J Antimicrob Chemother       Date:  2000-04       Impact factor: 5.790

6.  Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection.

Authors:  K H Edelmann; C B Wilson
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction.

Authors:  H N Lode; R Xiang; U Pertl; E Förster; S P Schoenberger; S D Gillies; R A Reisfeld
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

8.  CD154 stimulation of interleukin-12 synthesis in human endothelial cells.

Authors:  B Lienenlüke; T Germann; R A Kroczek; M Hecker
Journal:  Eur J Immunol       Date:  2000-10       Impact factor: 5.532

9.  The role of CD4+ T cell help and CD40 ligand in the in vitro expansion of HIV-1-specific memory cytotoxic CD8+ T cell responses.

Authors:  M A Ostrowski; S J Justement; L Ehler; S B Mizell; S Lui; J Mican; B D Walker; E K Thomas; R Seder; A S Fauci
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

10.  Early programming of T cell populations responding to bacterial infection.

Authors:  R Mercado; S Vijh; S E Allen; K Kerksiek; I M Pilip; E G Pamer
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

View more
  6 in total

Review 1.  Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends.

Authors:  William Y Ho; Cassian Yee; Philip D Greenberg
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  To ablate or not to ablate? HSCs in the T cell driver's seat.

Authors:  Claudio Anasetti; James J Mulé
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

3.  Dissecting CD8+ NKT Cell Responses to Listeria Infection Reveals a Component of Innate Resistance.

Authors:  Sergey S Seregin; Grace Y Chen; Yasmina Laouar
Journal:  J Immunol       Date:  2015-06-26       Impact factor: 5.422

Review 4.  The anticancer immune response: indispensable for therapeutic success?

Authors:  Laurence Zitvogel; Lionel Apetoh; François Ghiringhelli; Fabrice André; Antoine Tesniere; Guido Kroemer
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

5.  Anti-human immunodeficiency virus-gag CD8+ memory T cells generated in vitro from Listeria-immunized mice.

Authors:  Marina Rayevskaya; Natasha Kushnir; Fred R Frankel
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

6.  Nanocarriers for cancer nano-immunotherapy.

Authors:  Isra Rana; Jaeeun Oh; Juwon Baig; Jeong Hyun Moon; Sejin Son; Jutaek Nam
Journal:  Drug Deliv Transl Res       Date:  2022-10-03       Impact factor: 5.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.